Angiotensin II Type 1 Receptor Blockade Prevents Lethal Malignant Hypertension

Abstract

Angiotensin II type 1 receptor blockade by valsartan prevents lethal malignant hypertension independently of blood pressure. The results suggest that reduction of angiotensin-induced inflammation in the kidney may contribute to the protective effects of valsartan.